HB-EGF在Th17細(xì)胞誘導(dǎo)的哮喘氣道重塑進(jìn)程中的作用研究
發(fā)布時(shí)間:2021-09-08 11:32
一般認(rèn)為,Th17細(xì)胞通過特異性分泌IL-17而參與哮喘氣道重塑的發(fā)生發(fā)展,在該過程中,IL-17作為上游分子而發(fā)揮作用,但其下游效應(yīng)分子至今尚未明確。HB-EGF是EGF家族成員之一,與EGFR結(jié)合后能夠啟動(dòng)相應(yīng)的信號(hào)通路促進(jìn)多種氣道成分細(xì)胞的增生,是哮喘氣道重塑過程中最主要的下游分子之一。近來人們發(fā)現(xiàn),HB-EGF/EGFR通路可作為IL-17的下游通路參與骨關(guān)節(jié)炎、類風(fēng)濕關(guān)節(jié)炎、慢性腸炎以及銀屑病等自身免疫性疾病的發(fā)病。那么,在哮喘氣道重塑的進(jìn)程中,HB-EGF能否作為Th17細(xì)胞的下游效應(yīng)分子呢?我們以急性小鼠哮喘模型和慢性小鼠哮喘氣道重塑模型為研究對(duì)象,結(jié)合體外細(xì)胞共培養(yǎng)、Th17細(xì)胞過繼回輸以及單抗剔除等實(shí)驗(yàn)技術(shù)以期闡述HB-EGF在Th17細(xì)胞誘導(dǎo)的哮喘氣道重塑過程中的作用。本研究發(fā)現(xiàn):1、致敏小鼠在接受持續(xù)的變應(yīng)原刺激后,其氣道組織能夠分泌高水平的TGF-p、IL-6以及IL-23,并且高表達(dá)轉(zhuǎn)錄因子ROR-γt,有利于Th17細(xì)胞的定向分化。2、持續(xù)的變應(yīng)原霧化能夠誘導(dǎo)致敏小鼠氣道黏液分泌細(xì)胞增生、ASM細(xì)胞肥大和增生以及上皮下膠原纖維沉積等改變,Th17細(xì)胞過繼回輸...
【文章來源】:浙江大學(xué)浙江省 211工程院校 985工程院校 教育部直屬院校
【文章頁數(shù)】:91 頁
【學(xué)位級(jí)別】:博士
【部分圖文】:
反復(fù)持續(xù)的OVA霧化攻擊營(yíng)造了一個(gè)有利于Thl7細(xì)胞分化的微環(huán)境Figure3.ProlongedOVAehallengecreatedacytokineenvironmentthatfaeilitated
圖4.長(zhǎng)期變應(yīng)原暴露可促進(jìn)Tkl7型免疫應(yīng)答的產(chǎn)生Figure4.ProlongedallergenehallengeindueedincreasedThl7resPonseA)IL一17levelsinBALFfromsensit沈edmicechallengedwithOVAorPBSonday24(acutePhase)andondays35and55(ehronicPhase)weremeasuredbyELISA.B)eD4+IL一17+eellnumbersinlungsandparatracheally帥hnodes(pLN)fromaeuteandProlongedOVA一ehallengedmieeandPBSeontrolswereanalyzedbyfloweytometry.ThefrequeneyofCD4+IL一17+eellsinthelymphoeyteregionoftheforwar山sidescatterPlot15shown.ThenumbersindieatedaretheaveragedvaluesofthreeindePendentexPerhaents.26
圖6.IL一17單克隆抗體及EGFR抑制劑AG1478能夠減輕哮喘氣道重塑的嚴(yán)重度Figure6.anti一IL一17mAborAG1478administrationattenuatedProlongedOVA一indueedairwayremodeling.RePeatedOVAsensitizationandehallengeswerePerformedandanti一IL一17mAb,AG1478orisot鄧eIgGwereadministeredbeforenebulization.Mieewereeuthanxzedonday55.A)RePresentatlvePhotomierograPhsofPAS一,Massontriehrome一anda一SMA一stainedIungsectionsfromeaehgrouP.B)MueushyPer-secretion,subePithelialcollagendePositionandASMmassthic如esswereresPeetivelyquantifiedby(a)PASseore,theareaof(b)Massontrichlomestaining,(e)a一sMAstainingpermicrometerlengthofthebronehiolarbasementmembrane(林mZ/林m)and(d)levelsoftotalcollagenmeasuredinthelunghomogenate.C)IL一17exPression.TheresultsrePresentthemeans士SDoffourdifferentexPeriments.n=6/grouP.*P<0.05betweengrouPs.29
本文編號(hào):3390713
【文章來源】:浙江大學(xué)浙江省 211工程院校 985工程院校 教育部直屬院校
【文章頁數(shù)】:91 頁
【學(xué)位級(jí)別】:博士
【部分圖文】:
反復(fù)持續(xù)的OVA霧化攻擊營(yíng)造了一個(gè)有利于Thl7細(xì)胞分化的微環(huán)境Figure3.ProlongedOVAehallengecreatedacytokineenvironmentthatfaeilitated
圖4.長(zhǎng)期變應(yīng)原暴露可促進(jìn)Tkl7型免疫應(yīng)答的產(chǎn)生Figure4.ProlongedallergenehallengeindueedincreasedThl7resPonseA)IL一17levelsinBALFfromsensit沈edmicechallengedwithOVAorPBSonday24(acutePhase)andondays35and55(ehronicPhase)weremeasuredbyELISA.B)eD4+IL一17+eellnumbersinlungsandparatracheally帥hnodes(pLN)fromaeuteandProlongedOVA一ehallengedmieeandPBSeontrolswereanalyzedbyfloweytometry.ThefrequeneyofCD4+IL一17+eellsinthelymphoeyteregionoftheforwar山sidescatterPlot15shown.ThenumbersindieatedaretheaveragedvaluesofthreeindePendentexPerhaents.26
圖6.IL一17單克隆抗體及EGFR抑制劑AG1478能夠減輕哮喘氣道重塑的嚴(yán)重度Figure6.anti一IL一17mAborAG1478administrationattenuatedProlongedOVA一indueedairwayremodeling.RePeatedOVAsensitizationandehallengeswerePerformedandanti一IL一17mAb,AG1478orisot鄧eIgGwereadministeredbeforenebulization.Mieewereeuthanxzedonday55.A)RePresentatlvePhotomierograPhsofPAS一,Massontriehrome一anda一SMA一stainedIungsectionsfromeaehgrouP.B)MueushyPer-secretion,subePithelialcollagendePositionandASMmassthic如esswereresPeetivelyquantifiedby(a)PASseore,theareaof(b)Massontrichlomestaining,(e)a一sMAstainingpermicrometerlengthofthebronehiolarbasementmembrane(林mZ/林m)and(d)levelsoftotalcollagenmeasuredinthelunghomogenate.C)IL一17exPression.TheresultsrePresentthemeans士SDoffourdifferentexPeriments.n=6/grouP.*P<0.05betweengrouPs.29
本文編號(hào):3390713
本文鏈接:http://sikaile.net/yixuelunwen/huxijib/3390713.html
最近更新
教材專著